Moderna shares fall despite promising data from cancer vaccine trial

Read Time:6 Second

Moderna’s mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

They will pay a combined $9.3 million after the Securities and Exchange Commission charged them for exceeding clients' investment limits...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the...

Workers United represents more than 490 of Starbucks' U.S. cafes and more than 10,000 of its employees.

The changes come a day before Southwest's investor day, when executives will map out the company's plan to cut costs...

Birria has become a popular protein option for tacos, quesadillas, grilled cheese and even ramen.

Visa and MasterCard have surged in the past two decades, reaching a combined $1 trillion market cap. That has attracted...